Which men benefit from prostate cancer screening? Prostate cancer mortality by subgroup in the European Randomised Study of Screening for Prostate Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Prostate cancer screening effectiveness varied by age and location, with no single optimal age group identified. Screening benefits appear linked to duration and frequency, primarily by shifting diagnosis to earlier stages.
Area Of Science
- Urology
- Oncology
- Public Health
Background
- Prostate cancer (PCa) screening aims to reduce mortality.
- Identifying subgroups that benefit most from screening is crucial for personalized healthcare.
Purpose Of The Study
- To evaluate if specific age groups of men benefit more from prostate cancer screening than others.
- To analyze PCa mortality reduction across different age groups and European Association of Urology (EAU) risk categories.
Main Methods
- Retrospective cohort study involving 126,827 men aged 55-69 years across three European Randomised Study of Screening for Prostate Cancer (ERSPC) centers.
- Follow-up of up to 16 years, analyzing prostate cancer mortality as the primary outcome.
- Stratification by age groups (55-59, 60-64, 65-69) and EAU risk groups (low, intermediate, high, advanced disease).
Main Results
- Prostate cancer mortality reduction varied significantly by center and age group.
- Hazard ratios for PCa mortality showed differences across Finnish, Dutch, and Swedish centers.
- Mortality rates were substantially lower for men diagnosed with advanced disease, indicating a stage shift effect.
Conclusions
- The optimal age group for prostate cancer screening could not be unequivocally determined due to center and age-specific variations in mortality reduction.
- Screening effectiveness appears influenced by screening duration, number, and frequency of rounds.
- Prostate cancer mortality reduction observed is largely attributed to a shift towards earlier stage diagnoses.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....